Literature DB >> 2584409

Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.

R J Sokol1, S Hewitt, D J Booker.   

Abstract

Immunohaematological investigations were carried out in 46 patients with erythrocyte autoantibodies associated with myelodysplastic syndromes. Eight patients had refractory anaemia, 17 refractory anaemia with ring sideroblasts, 11 refractory anaemia with excess of blasts, four chronic myelomonocytic leukaemia, five refractory anaemia with excess of blasts in transformation and one could not be classified. Standard agglutination direct antiglobulin tests showed that the red cells were most often coated with IgG and C3d, though increased amounts of IgM or IgA were also found in 15 of 35 cases (43%) when the more sensitive enzyme linked method was used. The IgG antibodies were predominantly of IgG1 subclass. Clinically important autoimmune haemolysis occurred in 15 patients, and was of "warm", "cold," and "mixed" types in seven, four, and four cases, respectively: it is important to recognise its presence in view of the good response to treatment. The increased incidence of erythrocyte autoantibodies in myelodysplastic syndromes is thought to be one manifestation of disturbed immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584409      PMCID: PMC501869          DOI: 10.1136/jcp.42.10.1088

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  T cell function in refractory anaemia with excess blasts.

Authors:  P Colombat; M Renoux; J P Lamagnere; G Renoux
Journal:  Br J Haematol       Date:  1984-01       Impact factor: 6.998

2.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

3.  Frequency of alloantibodies accompanying autoantibodies.

Authors:  M L Laine; K M Beattie
Journal:  Transfusion       Date:  1985 Nov-Dec       Impact factor: 3.157

4.  Myelodysplastic syndromes: a scoring system with prognostic significance.

Authors:  G J Mufti; J R Stevens; D G Oscier; T J Hamblin; D Machin
Journal:  Br J Haematol       Date:  1985-03       Impact factor: 6.998

Review 5.  Autoimmune hemolysis: a critical review.

Authors:  R J Sokol; S Hewitt
Journal:  Crit Rev Oncol Hematol       Date:  1985       Impact factor: 6.312

6.  Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases.

Authors:  P Solal-Celigny; B Desaint; A Herrera; C Chastang; M Amar; M Vroclans; N Brousse; F Mancilla; M Renoux; J F Bernard
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

7.  Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection.

Authors:  M A Wallhermfechtel; B A Pohl; H Chaplin
Journal:  Transfusion       Date:  1984 Nov-Dec       Impact factor: 3.157

8.  Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy.

Authors:  R J Sokol; S Hewitt; B K Stamps
Journal:  Vox Sang       Date:  1982       Impact factor: 2.144

9.  Decreased T helper cells in the myelodysplastic syndromes.

Authors:  A G Bynoe; C S Scott; P Ford; B E Roberts
Journal:  Br J Haematol       Date:  1983-05       Impact factor: 6.998

10.  Immune abnormalities in myelodysplastic syndromes.

Authors:  T Economopoulos; J Economidou; G Giannopoulos; C Terzoglou; E Papageorgiou; J Dervenoulas; P Arseni; J Hadjioannou; S Raptis
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

View more
  8 in total

Review 1.  The pathology of autoimmune haemolytic anaemia.

Authors:  R J Sokol; D J Booker; R Stamps
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 2.  Transient myelofibrosis with autoimmune pancytopenia: a case report.

Authors:  Tomohei Nakao; Takashi Fukushima; Takashi Shimizu; Toru Nanmoku; Satoshi Fujiyama; Ryoko Nakajima; Fujiko Fukushima; Masayuki Noguchi; Ryo Sumazaki
Journal:  Eur J Pediatr       Date:  2008-11-06       Impact factor: 3.183

3.  Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemia.

Authors:  H Tamura; K Ogata; N Yokose; E An; K Kamikubo; K Dan; E Kajii; T Nomura
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

4.  A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based study.

Authors:  Johanne Rozema; Christiaan L Slim; Nic J G M Veeger; Robby E Kibbelaar; Harry de Wit; Eric N van Roon; Mels Hoogendoorn
Journal:  Blood Transfus       Date:  2020-12-16       Impact factor: 3.443

5.  Case report: paroxysmal cold hemoglobinuria presenting during pregnancy.

Authors:  Andrea O Akpoguma; Thomas L Carlisle; Steven R Lentz
Journal:  BMC Hematol       Date:  2015-02-13

6.  Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.

Authors:  Bradley T Williamson; Lynda Foltz; Heather A Leitch
Journal:  Hematol Rep       Date:  2016-05-10

Review 7.  Autoimmune Complications in Hematologic Neoplasms.

Authors:  Wilma Barcellini; Juri Alessandro Giannotta; Bruno Fattizzo
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

8.  Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome.

Authors:  J X Zou; D E Rollison; D Boulware; D-T Chen; E M Sloand; L V Pfannes; J J Goronzy; F Bai; J S Painter; S Wei; D Cosgrove; A F List; P K Epling-Burnette
Journal:  Leukemia       Date:  2009-03-12       Impact factor: 12.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.